| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2002-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e5378866a6e780c24c06fb80eec572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f9a159f243a495aec4d256074644291
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf05d4f98c38e4cd5dfcad086cb2828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85ee5888edc7339a7056afb8be78cdfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c77936fce552d2606835f91c46d9f71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2d8d42fde550d57056e4711f8b862c8 |
| publicationDate |
2004-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1469065-A1 |
| titleOfInvention |
Composition of antibody specifically binding to cd20 |
| abstract |
The present invention provides an antibody composition which specificallynbinds to CD20 and comprises an antibody molecule which has complex N-glycoside-linkednsugar chains bound to the Fc region; a process for producing the antibodyncomposition; and a medicament comprising the antibody composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1705251-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1500698-A4 |
| priorityDate |
2001-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |